Jain S, Griffith JI, Porath KA, Rathi S, et al. Bystander effects, pharmacokinetics, and linker-payload stability of EGFR-targeting antibody-drug conjugates Losatuxizumab vedotin and Depatux-M in glioblastoma models. Clin Cancer Res 2024 May 14. doi: 10.1158/1078-0432.CCR-24-0426.
PMID: 38743766